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Abstract 
Introduction: Operative times can be accurately predicted with feedback and knowledge of the 
key variables. Our study aimed to utilize the International Robotic Cystectomy Consortium 
(IRCC) database of robot-assisted radical cystectomy (RARC) to determine patient and 
institutional variables of importance in predicting operative times.  
Methods: IRCC database includes 2686 RARCs performed at 23 institutions from 12 countries. 
The model included variables that are available in the preoperative period used and therefore can 
be used for prediction of surgical times: institutional RARC volume, age at RARC, gender, BMI, 
ASA Score, history of prior abdominal surgery and radiation, clinical stage of disease, 
administration of neoadjuvant chemotherapy, type and technique of diversion and the extent of 
pelvic lymph node dissection. A conditional inference tree method was used to fit a binary 
decision tree predicting operative time.  Permutation tests were performed to determine the 
variables having the strongest association with RARC surgical time.  The data was split at the 
value of this variable resulting in the largest difference in means for the surgical time across the 
split. This process was repeated recursively/iteratively on the resultant data sets until the 
permutation tests showed no significant association between any of the explanatory variables and 
operative time.  
Results: 2135 procedures were included in the analysis. The variable most strongly associated 
with surgical time was the type of diversion (ileal conduits - 69 minutes shorter than 
neobladders, p<0.001). Among patients who received neobladders, type of lymph node 
dissection (LND) was also strongly associated with surgical time. Among the Ileal conduit 
patients, institutional surgeon volume (>66 RARCs) was an important factor (higher volume—
54 minutes shorter, p<0.001). The regression tree output was in the form of box plots that show 
the median, interquartile deviation, and ranges of surgical times according to the patient, disease 
and institutional characteristics.   
Conclusion: We developed a methodology utilizing a large database to estimate operative times 
for RARC based on patient, disease and institutional metrics.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
An operating room (OR) is considered to be one of the most costly functional areas 
within hospitals as well as its major profit center. It is known that managing an OR department is 
a challenging task, which requires the integration of many actors (e.g., patients, surgeons, nurses, 
technicians) who may have conflicting interests and priorities. Considering these aspects, this 
paper focuses on developing a methodology for scheduling operating rooms that reflects the 
complexity, and variability associated with surgery.  
Radical cystectomy (RC) with urinary diversion is a complex surgery associated with 
significant morbidity and cost 
1
. RCs performed with robot-assistance has grown dramatically 
(<1% to 13%) between 2004 and 2010 
2
. Despite the benefits of robot-assisted radical 
cystectomy (RARC) in terms of perioperative outcomes such as blood loss, hospital stay and 
recovery, it has been criticized for long operative times and the associated cost. Although RARC 
was associated with shorter hospital stay ($ 658 a day) when compared to open RC, it was also 
associated with significantly longer operative times ($ 1902 an hour). Continuous refinement of 
the technique and expertise may cause additional cutting down of operative times and costs 
3
.  
For RC, prolonged operative times have been associated with higher incidence of 
complications and perioperative mortality independent of the disease stage or associated 
comorbidities 
4
. Additionally, longer operative times have been directly associated with 
increased healthcare costs, where each operating room (OR) minute was found to add $15 to the 
overall hospital charges 
5
. Not surprisingly, operative time has been identified as a quality 
measure for surgical performance for RARC 
6,7
. 
Scheduling OR time for RARC is a challenging task owing to the complexity and 
reconstructive nature of the procedure. Patients have multiple confounding factors that contribute 
to variation in operative time for RARC, including patient demographics and comorbidities, 
disease stage, procedural complexity, technical modifications, surgeon experience and hospital 
volume 
8
. In this context, we sought to develop a statistical model that incorporates different 
preoperative data, including patient, disease, surgical and institutional variables, to estimate 
operative times for RARC at the individual patient level.  
Methods: 
A retrospective review of 2686 RARCs performed at 23 institutions from 12 countries 
included in the International Robotic Cystectomy Consortium (IRCC) database (I-97906) was 
performed. For prediction of operative time (from incision to wound closure), we included all the 
relevant patient, disease, technical and institutional variables that can be assessed preoperatively 
and therefore can be included in a predictive model. Patient factors included: age, gender, body 
mass index (BMI), the American Society of Anesthesiologists (ASA) score, prior history of 
abdominal surgery or irradiation. Disease factors included preoperative clinical staging. 
Technical factors included the receipt of neoadjuvant chemotherapy, planned type and technique 
of diversion, and extent of pelvic lymph node dissection (pLND). The overall RARC 
institutional volume was also included in the model.  
Descriptive statistics were used to summarize the data. A conditional-inference tree 
method was used to fit a binary decision tree predicting the distribution of operative times.  
Permutation tests were performed to determine the variable having the strongest association with 
RARC surgical time.  The data was split at the value of this variable resulting in the largest 
difference in means for the surgical time across the split This process was repeated recursively 
on the resultant data sets until the permutation tests showed no significant association between 
any of the explanatory variables and operative time. The resulting data sets are known as 
terminal nodes or leaves. 
The output of the software package was in the form of box plots depicting the median, 
interquartile ranges, the minimum and the maximum duration of operative times within each 
terminal node.  Operative times are generally known to be lognormally distributed 
9
.  Within 
each terminal node a lognormal model was also fit to the operative times of patients included in 
the node. This lognormal model fit allows any quantity associated with the distribution of 
operative times to be estimated. 
All tests were two-sided, with statistical significance defined as p<0.05. All statistical 
analyses were performed using R software (version 3.2, R Core Team (2016). R: A language and 
environment for statistical computing  (R Foundation for Statistical Computing, Vienna, Austria. 
URL https://www.R-project.org/). 
Results 
The final analysis comprised 2135 RARCs (Table 1).  Mean age was 67 years (standard 
deviation [SD] 10), 74% were males. Sixteen percent had clinical extravesical disease and 20% 
received neoadjuvant chemotherapy. Seventy eight percent received ileal conduits and 69% had 
an intracorporeal diversion. Median operative time was 364 minutes (Interquartile range [IQR] 
300-447). Fifty seven percent had extended, 35% had standard LND and 39% of patients had 
≥20 lymph nodes on the final pathology (Table 1). There was a trend towards shorter operative 
times for RARC, decreasing from a mean of 373 minutes in 2006 to 323 minutes in 2015 
(p=0.052) (Figure 1).  
The variable most strongly associated with surgical time was the type of diversion and it 
resulted in the largest mean difference (ileal conduit—69 minutes shorter than neobladders, 
p<0.001).  Among patients who received neobladders, the extent of LND was the most strongly 
associated with RARC time. Extended or standard LNDs were 26 minutes on average longer 
than limited or no LND dissection (p<0.001). Whatever the extent of LND, having a lower BMI 
was significantly associated with at least 33 minutes shorter operative time (Figure 2).  
Among patients who received ileal conduits, surgeon volume > 66 procedures was 
significantly associated with shorter operative times (56 minutes, p<0.001). Again, whatever the 
surgeon volume was, lower BMI was significantly associated with shorter operative times 
(p<0.001). For lower volume surgeons (<66 RARCs) and BMI ≤ 30 kg/m2, the extent of LND 
further affected operative time (20 minutes longer in extended or standard LND, p<0.001). For 
patients who underwent standard or extended pLND, prior abdominal surgery and surgeon 
volume (41 RARCs) were also significantly associated with shorter operative times (p < 0.001) 
(Figure 2). 
 The longest estimated operative times were observed in patients who received 
neobladders and underwent limited or no LND and with BMI > 41 kg/m
2 
(Node 5; median 461 
minutes, IQR 390-571 minutes). On the other hand, the shortest estimated operative times were 
patients who received ileal conduits , had BMI ≤ 30 kg/m2 , underwent standard or extended 
LND, did not have any prior surgery and RARC performed surgeons with volume 42-66 RARCs 
(Node 16: median 284, IQR 264-340 minutes) (Figure 2) (Table 2). 
The use of the binary decision tree is best illustrated with an example.  Assume a 
urologist who has performed 50 RARCs had a patient whose BMI is 26 Kg/m
2
 and no prior 
abdominal surgery. The patient is to be scheduled for a RARC with an ileal conduit and extended 
LND. Starting at the top of the tree(Figure 2), we proceed to the right due to the scheduled ileal 
conduit. Then, at node 9 we proceed left due to the surgeon’s volume of 25 RARCs.  At node 10 
we proceed left due to the patient’s BMI.  At node 11 we again proceed left due to the planned 
extended LND.  At node 12 we proceed to the right because the patient has no history of 
abdominal surgery.  Finally we proceed right, again due to the surgeon experience, ending in 
node 16.  From Table 2 we can now see that similar surgeries had a mean operative time of 307 
minutes (SD 60 minutes).  Similarly the minimum, maximum, median and IQR for similar 
surgeries is readily available in Table 2. 
Discussion 
Bladder cancer is one of the most expensive cancers to manage 
1,10
. Bearing this in mind, 
it is vital to explore the association between patient, disease, surgeon, and institutional factors 
with RC operative times. Within hospitals, ORs have been identified as the key financial 
component, where they contribute to more than 40% of hospitals’ revenue 11. On the other hand, 
costs associated with staffing and equipment rendered OR utilization very expensive, accounting 
for approximately 30% of the total hospital expenditure 
12
. Late starting or finishing times and 
large time gaps between surgeries can lead to suboptimal OR utilization. Consequently, attempts 
are made to optimize the OR availability to maximize profitability, minimize expenditure (costs 
associated with staffing, especially the overtime cost), and limit under-utilization.  
Scheduling operative times can be done via various methods.  Common strategies 
include: open (assigning an OR at the convenience of surgeons), block scheduling (surgeons are 
assigned time blocks into which they arrange their procedures) and modified block scheduling 
(some time is blocked and some is left open and any unused time can be released) 
13
. The key to 
maximizing OR utilization is to determine the appropriate block time for each kind of surgery, 
considering the different variables that may affect it. Accurate estimates of operative times 
would facilitate scheduling, service planning and maximize the utility of the OR. Historical data, 
such as the average time for the last ten cases, average surgeon’s list or surgeon’s estimate have 
been proposed as means for estimating scheduled operative times 
14
. However, none of these 
methods have shown a reliable predictive validity 
14
. As a result, OR utilization can be as low as 
80% of the target, which has substantial financial implications 
15
.  
Surgery planning and scheduling offers unique challenges owing to the amount of 
associated uncertainty. It requires integration of multiple and variable factors, including patient, 
surgical team, disease, technical, surgeon and institutional factors. Not only that, each patient is 
unique and therefore, even for the same procedure, the scheduled time for one patient may not be 
appropriate for another. Different statistical methods have been proposed, including linear 
regression, generalized linear, and intelligent-based models 
9
. Selection of a model should be 
based on examination of the data distribution, where linear regression can be used in cases of 
normal distribution. Recently, there has been a trend towards incorporating intelligent-based 
models and data mining techniques such as rough sets, artificial neural networks and fuzzy 
inference systems to predict procedure times, despite initial unsatisfactory results 
16
. We utilized 
a multi-level conditional-inference tree model that can handle complex interactions between 
variables, and determine the contribution of each variable at each level. Tree-based models have 
several advantageous features including scalability to large numbers of explanatory variables and 
subjects, simplicity of model interpretation and ease of use by the non-statistician. These models 
are also adept at fitting data that is far from normally distributed. Utilizing this model we were 
able to estimate operative times at the individual patient level.  
Filson et al examined the different factors that may contribute to operative times. They 
divided them into potentially modifiable (such as  perioperative procedures, LND, and diversion 
type and technique), non-modifiable patient factors (such as age and sex) and institutional and 
surgeon factors 
8
. Similar to our study, they observed longer operative times with neobladders 
and with more extensive LNDs. Older age and the number of comorbidities were significantly 
associated with shorter operative times 
17
. Surgeons are usually concerned of the potential higher 
anesthetic complications in older and sicker patients. Female patients were also found to have 
longer operative times (possibly because of performance of hysterectomy and vaginal 
reconstruction) 
8
. This is in contrast to the current and prior studies 
18
. BMI and prior abdominal 
surgery were significantly associated in our study with operative times. Higher BMI and prior 
abdominal surgery add to the complexity of RARC, with more time spent in port placement, 
careful dissection as well as LND 
17,19
. 
High-volume institutions had shorter operative times for RC. This may be attributed to 
the experience of the surgeon and the team at those institutions 
8
. Institutional volume, however, 
was not significantly associated with operative times in our study. This may be explained by the 
fact that the IRCC includes mainly high volume institutions, which limits any conclusions drawn 
about the institutional volume. Other studies have shown clear association with hospital type, 
where academic centers had longer operative times (approximately 40 minutes longer). 
Academic centers involve postgraduate trainees (residents and fellows in anesthesia and 
urology), and they are also more likely to perform extended LNDs, intracorporeal diversion and 
neobladders 
20
. In agreement with our findings, a significant decrease in operative time was 
associated with higher surgeon volume 
21,22
. The cut off for surgical proficiency for RARC is 
higher in our study than previously reported (22 RARCs) 
23
. In our study, surgeons who had 
performed at least 66 RARCs saved an average of 54 minutes of operative time among patients 
who underwent ileal conduits (Nodes 10 (mean 396 minutes) vs 19 (mean 340 minutes), 
p<0.001). A surgeon volume of 44 RARCs resulted in a savings of 77 minutes on average for 
patients who underwent extended LND (Nodes 15 (384 minutes) vs 16 (307 minutes), p<0.001). 
This highlights the importance of fellowship training and dedicated cystectomy programs where 
surgeons can increase their RARC volume 
24,25
.  
Despite the uniqueness of this study, several limitations exist. The retrospective study 
design has its recognized limitations. Any surgical procedure typically involves three stages: pre-
surgery, surgery and post-surgery. The actual procedural duration (time elapsed from incision to 
wound closure) is the amount of time during which surgery occurs and corresponds to the 
defined Current Procedure Terminology (CPT) codes. Most databases do not account for non-
operative times that include delays in patient arrival, times related to anesthesia induction, 
patient discharge and turnover times (cleaning and preparing the OR for the next patient). 
Although the actual operative time would likely be shorter than the overall OR time, a reliable 
OR schedule can only be achieved when accurate estimates about the time needed to perform the 
surgery is available 
26
. Otherwise, operations that take significantly longer or shorter than 
predicted will increase the chance of OR underutilization. We believe that some variability 
between scheduled and actual procedures cannot be avoided, especially those arising due to 
unexpected intraoperative findings. Another limitation of our study was the inability to account 
for the heterogeneity of teams and ORs due to the multi-institutional nature of the IRCC 
database.  
Conclusion  
We developed a methodology utilizing a large database to estimate operative times for 
RARC based on patient, disease and institutional metrics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Perioperative outcomes of 2135 patients who received RARC 
Variable Value 
Number of patients, n  2135 
Preoperative characteristics 
Age at cystectomy, mean (SD) (years) 67 (10) 
Sex, Males, n (%) 1578 (74) 
BMI, mean (SD) (kg/m
2
) 28 (5) 
ASA score, mean (SD) 2.4 (0.7) 
Prior abdominal/pelvic surgery, n (%) 580 (46) 
NAC, n (%) 400 (20) 
Clinical T stage ≥ 3, n (%) 302 (16) 
Operative outcomes 
Type of diversion, Ileal conduit, n (%) 1553 (78) 
Location of diversion, Intracorporeal, n (%) 1006 (69) 
Operative time, median  (IQR) (minutes) 364 (300-447) 
EBL, median (IQR) (ml) 300 (200-500) 
No LND, n (%) 103 (9) 
Limited LND, n (%) 9 (1) 
Standard LND 412 (35) 
Extended LND, n (%) 666 (57) 
Pathologic outcomes 
pT3/T4, n (%) 776 (39) 
LNY, mean (SD) 18.4 (11) 
LNY ≥ 20, n (%) 726 (39) 
N1, n (%) 499 (23) 
Positive soft tissue surgical margins, n (%) 144 (7) 
Postoperative outcomes 
Adjuvant chemotherapy, n (%) 262 (16) 
Hospital stay, median (IQR) (months) 9 (6-13) 
ICU stay, median (IQR) 1 (0-1) 
Complications within 30 days, n (%) 559 (26) 
Complications ≥ Clavien 3 within 30 days, n (%) 164 (8) 
Complications within 90 days, n (%) 653 (31) 
Complications ≥ Clavien 3 within 90 days, n (%) 202 (10) 
Readmissions within 30 days, n (%) 115 (5) 
Readmissions within 90 days, n (%) 197 (9) 
Mortality within 30 days, n (%) 14 (1) 
Mortality within 90 days, n (%) 51 (3) 
Follow up, median (IQR) (months) 12.4 (5-27) 
RARC, robotic-assisted radical cystectomy; n, number; SD, standard 
deviation; BMI, body mass index; Kg/m
2
, kilogram per meter squared; ASA 
score, American Society of Anesthesiologists; LN, lymph node; NAC, 
neoadjuvant chemotherapy; LND; lymph node dissection; EBL, estimated 
blood loss; LNY, lymph node yield 
 
 
Table 2. Median, IQR, mean, SD and ranges for operative times for each Node. 
Node Patients 
at Node 
(n) 
Mean 
operative 
time 
(minutes) 
SD 
(minutes) 
Minimum 
operative 
time 
(minutes) 
25
th
 
percentile 
(minutes) 
Median 
operative 
time 
(minutes) 
75
th
 
percentile 
(minutes) 
Maximum 
operative 
time 
(minutes) 
4 326 438 114 157 375 434 501 760 
5 40 471 114 260 390 461 571 680 
7 74 390 93 159 345 375 448 600 
8 62 446 100 240 375 444 495 720 
13 59 379 99 210 308 350 435 618 
15 51 384 63 240 342 389 417 600 
16 21 307 60 239 264 284 340 440 
17 415 390 108 200 313 370 457 862 
18 166 430 108 200 360 420 490 780 
20 715 332 89 159 270 318 378 827 
21 205 371 100 172 300 360 420 830 
 
Figure 1. Mean operative times for RARC between 2005 and 2015 (p=0.052) 
 
 
 
 
 
 
 
Figure 2. Regression tree showing the outcome as Box plots for each Node. 
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